Table 2.

Epidemiologic and Clinical Characteristics of Patients With Invasive Haemophilus influenzae Serotype a Disease—United States and Alaska, 2008–2017

CharacteristicsUnited Statesa (N = 386)Alaska(N = 49)
Age in years, median (range)30 (0–92)1 (0–77)
Sex, %
 Male50.061.2
Race, %
 White59.34.1
 Black14.80.0
 AI/AN14.893.9
 Asian/PI1.32.0
 Unknown9.80.0
Ethnicity, %
 Hispanic/Latino15.0N/A
 Non-Hispanic/Latino68.1N/A
 Unknown16.8N/A
Clinical syndrome,b %
 Bacteremic pneumonia41.318.4
 Bacteremia32.012.2
 Meningitis23.938.8
 Septic arthritis7.816.3
 Cellulitis4.412.2
 Epiglottitis3.90.0
 Other invasive disease0.52.1
Hospitalized, %94.887.8
 Duration of hospitalization in days, median (range)7 (0–126)8 (0–68)
Died,c %7.810.2
CharacteristicsUnited Statesa (N = 386)Alaska(N = 49)
Age in years, median (range)30 (0–92)1 (0–77)
Sex, %
 Male50.061.2
Race, %
 White59.34.1
 Black14.80.0
 AI/AN14.893.9
 Asian/PI1.32.0
 Unknown9.80.0
Ethnicity, %
 Hispanic/Latino15.0N/A
 Non-Hispanic/Latino68.1N/A
 Unknown16.8N/A
Clinical syndrome,b %
 Bacteremic pneumonia41.318.4
 Bacteremia32.012.2
 Meningitis23.938.8
 Septic arthritis7.816.3
 Cellulitis4.412.2
 Epiglottitis3.90.0
 Other invasive disease0.52.1
Hospitalized, %94.887.8
 Duration of hospitalization in days, median (range)7 (0–126)8 (0–68)
Died,c %7.810.2

Abbreviations: AI/AN, American Indian and Alaska Native; N/A, not available; PI, Pacific Islander.

aNote: data shown in this column are from Active Bacterial Core surveillance sites and do not include all cases in the United States.

bInformation on clinical syndrome was available for 385/386 (99.7%) cases in the United States and 49/49 (100%) cases in Alaska. Clinical syndrome was not mutually exclusive.

cInformation on outcome was available for 384/386 (99.5%) cases in the United States and 49/49 (100%) cases in Alaska.

Table 2.

Epidemiologic and Clinical Characteristics of Patients With Invasive Haemophilus influenzae Serotype a Disease—United States and Alaska, 2008–2017

CharacteristicsUnited Statesa (N = 386)Alaska(N = 49)
Age in years, median (range)30 (0–92)1 (0–77)
Sex, %
 Male50.061.2
Race, %
 White59.34.1
 Black14.80.0
 AI/AN14.893.9
 Asian/PI1.32.0
 Unknown9.80.0
Ethnicity, %
 Hispanic/Latino15.0N/A
 Non-Hispanic/Latino68.1N/A
 Unknown16.8N/A
Clinical syndrome,b %
 Bacteremic pneumonia41.318.4
 Bacteremia32.012.2
 Meningitis23.938.8
 Septic arthritis7.816.3
 Cellulitis4.412.2
 Epiglottitis3.90.0
 Other invasive disease0.52.1
Hospitalized, %94.887.8
 Duration of hospitalization in days, median (range)7 (0–126)8 (0–68)
Died,c %7.810.2
CharacteristicsUnited Statesa (N = 386)Alaska(N = 49)
Age in years, median (range)30 (0–92)1 (0–77)
Sex, %
 Male50.061.2
Race, %
 White59.34.1
 Black14.80.0
 AI/AN14.893.9
 Asian/PI1.32.0
 Unknown9.80.0
Ethnicity, %
 Hispanic/Latino15.0N/A
 Non-Hispanic/Latino68.1N/A
 Unknown16.8N/A
Clinical syndrome,b %
 Bacteremic pneumonia41.318.4
 Bacteremia32.012.2
 Meningitis23.938.8
 Septic arthritis7.816.3
 Cellulitis4.412.2
 Epiglottitis3.90.0
 Other invasive disease0.52.1
Hospitalized, %94.887.8
 Duration of hospitalization in days, median (range)7 (0–126)8 (0–68)
Died,c %7.810.2

Abbreviations: AI/AN, American Indian and Alaska Native; N/A, not available; PI, Pacific Islander.

aNote: data shown in this column are from Active Bacterial Core surveillance sites and do not include all cases in the United States.

bInformation on clinical syndrome was available for 385/386 (99.7%) cases in the United States and 49/49 (100%) cases in Alaska. Clinical syndrome was not mutually exclusive.

cInformation on outcome was available for 384/386 (99.5%) cases in the United States and 49/49 (100%) cases in Alaska.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close